Centrum Medyczne ENEL-MED (WAR:ENE) ROA %: 0.60% (As of Mar. 2026)


WAR:ENE Centrum Medyczne ENEL-MED SA WAR:ENE
78 GF Score
Price zł19.20
GF Value zł24.91
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED ROA %?

Centrum Medyczne ENEL-MED WAR:ENE 78 ROA % is 0.60% as of Mar. 2026. GuruFocus rates WAR:ENE with a GF Score™ of 78/100 and a GF Value™ of zł24.91 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Centrum Medyczne ENEL-MED ranks worse than 55.1% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Centrum Medyczne ENEL-MED's annualized Net Income for the quarter that ended in Mar. 2026 was zł3.9 Mil. Centrum Medyczne ENEL-MED's average Total Assets over the quarter that ended in Mar. 2026 was zł646.0 Mil. Therefore, Centrum Medyczne ENEL-MED's annualized ROA % for the quarter that ended in Mar. 2026 was 0.60%.

The historical rank and industry rank for Centrum Medyczne ENEL-MED's ROA % or its related term are showing as below:

WAR:ENE' s ROA % Range Over the Past 10 Years
Min: -5.42   Med: -0.35   Max: 2.8
Current: 1.29

During the past 13 years, Centrum Medyczne ENEL-MED's highest ROA % was 2.80%. The lowest was -5.42%. And the median was -0.35%.

WAR:ENE's ROA % is ranked worse than
55.1% of 686 companies
in the Healthcare Providers & Services industry
Industry Median: 1.75 vs WAR:ENE: 1.29

Centrum Medyczne ENEL-MED  (WAR:ENE) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=3.884/646.029
=(Net Income / Revenue)*(Revenue / Total Assets)
=(3.884 / 942.816)*(942.816 / 646.029)
=Net Margin %*Asset Turnover
=0.41 %*1.4594
=0.60 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Centrum Medyczne ENEL-MED ROA % Related Terms


Centrum Medyczne ENEL-MED ROA % Historical Data

* Premium members only.

The historical data trend for Centrum Medyczne ENEL-MED's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centrum Medyczne ENEL-MED ROA % Chart

Centrum Medyczne ENEL-MED Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 -5.42 1.69 2.80 2.19

Centrum Medyczne ENEL-MED Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.55 -1.92 5.05 1.36 0.60

WAR:ENE vs HCA, THC, DVA: ROA % Comparison

For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centrum Medyczne ENEL-MED ROA % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's ROA % distribution charts can be found below:

* The bar in red indicates where Centrum Medyczne ENEL-MED's ROA % falls into.


WAR:ENE
78GF Score
Centrum Medyczne ENEL-MED SA WAR:ENE
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centrum Medyczne ENEL-MED ROA % Calculation

Centrum Medyczne ENEL-MED's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=12.892/( (536.973+638.833)/ 2 )
=12.892/587.903
=2.19 %

Centrum Medyczne ENEL-MED's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=3.884/( (638.833+653.225)/ 2 )
=3.884/646.029
=0.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of 0.60% mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a ROA % of 0.60% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Centrum Medyczne ENEL-MED and its competitors. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #378 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 55.1%.
Is Centrum Medyczne ENEL-MED's ROA % too high?
Centrum Medyczne ENEL-MED's current ROA % is 0.60%. The Healthcare Providers & Services industry median ROA % is 1.75. Centrum Medyczne ENEL-MED's value of 0.60% is 65.7% below this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #378 out of 686 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #378 out of 686 companies for ROA %. This places Centrum Medyczne ENEL-MED in the lower half of its industry. The industry median ROA % is 1.75. Centrum Medyczne ENEL-MED's value of 0.60% is 65.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current ROA % of 0.60% is 65.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current ROA % is 0.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł24.91, compared to a current price of zł19.20 — trading 22.9% below its estimated fair value. The current ROA % is 0.60% and 65.7% below the Healthcare Providers & Services industry median of 1.75. Centrum Medyczne ENEL-MED's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current ROA % is 0.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of zł19.20 is trading 22.9% below its estimated GF Value™ of zł24.91. GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.

Key valuation signals for WAR:ENE:

  • ROA %: 0.60%
  • GF Value™: zł24.91 vs. price of zł19.20 (22.9% below fair value)
  • GF Score™: 78/100 with 5 warning signs
  • Industry Position: 65.7% below the Healthcare Providers & Services median (#378 of 686)

No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centrum Medyczne ENEL-MED Business Description

Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
78GF Score

Get the complete analysis for WAR:ENE

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł19.20
Price
zł24.91
GF Value